Sterile Focus Brands and third party manufacturing are the most material contributors to revenue in this region. The active pharmaceutical ingredient (“API”) site in The Netherlands, supported by its satellite operation at Sioux City, in the United States supplies APIs worldwide. We provide a broad range of sterile medicines in Europe largely utilised in an acute hospital setting.

Within the Sub-Saharan Africa business local brands have strong brand equity and continue to contribute positively to Aspen’s leading presence in the South African market. We also supply OTC brands in various home markets outside South Africa, mainly in Namibia, Botswana, Tanzania, Kenya, Nigeria, Ghana and Uganda.

Australia is the third largest region by revenue contribution, supported by strong sales teams promoting a diversified portfolio of prescription, OTC and consumer health products. Aspen’s production facilities are also one of the largest manufacturing sites in Australia, with an ability to produce tablets, liquids and semi-solids.

Latin America includes a portfolio of locally recognised and trusted brands sold across the public and private sector. Brazil and Mexico are the biggest contributors to regional performance.

The main revenue contributor to our Developing Europe & CIS business is the Thrombosis Brands, followed by Regional Brands which are OTC and prescription.

Aspen China offers a select portfolio of products with which Aspen can effectively compete. China’s revenue is largely from Sterile Focus Brands, offering products which are both niche and aligned with market trends in the region.

Other Asia comprises all Asian territories excluding China. We have active trading subsidiaries in the Philippines, Taiwan and Malaysia. Therapies that dominate in these regions include Anaesthetics and certain Regional Brands. Our manufacturing facility in India is our primary new product development site.

The region supplies products with international brand equity, as well as regionally recognised medicines which are supplied across multiple territories within Middle East and North Africa (“MENA”).

Aspen USA & Canada revenues are almost equally split in Anaesthetics and Regional Brands. Our satellite API facility in Sioux City supports the Oss site in supplying APIs worldwide.